STAT Summit

Health tech Mohana Ravindranath

STAT Plus: Microsoft’s Peter Lee says ChatGPT shouldn’t be used for initial diagnosis

Pharma Matthew Herper

STAT Plus: Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers

Biotech Jason Mast

STAT Plus: Patient advocates clash over wisdom of ‘approving drugs faster and faster’

Biotech Allison DeAngelis and Mario Aguilar

STAT Plus: How biotech investors spot opportunity when stocks are down — and up

Biotech Elizabeth Cooney

STAT Plus: Drug development was once a marathon. New tools and timelines are turning it into a sprint

STAT Madness Theresa Gaffney

Male birth control research wins audience over at STAT Madness event

The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein

Live! From the STAT Breakthrough Summit East

Health Lev Facher

Top U.S. addiction researcher calls GLP-1 data for addiction ‘very, very exciting’

Health Lev Facher

STAT Plus: Ibogaine, the psychedelic, unlikely to receive approval as opioid treatment, says top addiction researcher

Biotech Damian Garde

STAT Plus: Regeneron’s plot to ‘cure’ allergies

Biotech Annalisa Merelli

STAT Plus: Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help?

Biotech Andrew Joseph

STAT Plus: Feng Zhang suggests Editas didn’t move quickly enough to find product targets

STAT Staff

An Ask Me Anything with STAT’s Nicholas St. Fleur

Health Annalisa Merelli

Fixing America’s health insurance woes is ‘actually very simple,’ says leading economist

Health Anika Nayak

What will it take to end the crisis of Black deaths in the U.S.?

Health Isabella Cueto

Meghan O’Rourke on a medical system not built for chronic illness — and the ‘invisible kingdom’ that could spur change

Health Deborah Balthazar

How an ER doctor in Chicago is tackling trauma from gun violence

Health tech Lizzy Lawrence

STAT Plus: Doctor vs. ChatGPT showed promise and blind spots of generative AI

Biotech Annalisa Merelli

STAT Plus: How biotech deal-making really works behind the scenes, according to founders

Health Lev Facher

The fight for control of methadone, addiction treatment’s ‘miracle molecule’

Politics Brittany Trang

STAT Plus: HHS leader on health and climate change talks health sector emissions and heat emergencies

Pharma Elizabeth Cooney

STAT Plus: GSK CEO on pharma giant’s new direction: ‘We’re in the business of preventing and treating disease’

Health Theresa Gaffney

Michael J. Fox on how far Parkinson’s research has come: ‘We don’t want to be celebrated. We want to get things done’

Biotech Damian Garde

STAT Plus: The future of Biogen: Pragmatism, ‘a few moonshots,’ and no Twinkies

Biotech Megan Molteni

STAT Plus: Zuckerberg and Chan on track to put $50 billion toward science: ‘That’s the trajectory we’re on’

Politics John Wilkerson

STAT Plus: Actually, hospital price transparency does save money, advocate highlights

Hospitals Allison DeAngelis

STAT Plus: Dana-Farber executive says split from Mass General will benefit patients

Biotech Jonathan Wosen

STAT Plus: Biotech power broker John Maraganore offers advice to the next crop of entrepreneurs

In the Lab Anika Nayak

How rising stars in science and medicine think about mentorship and bouncing back from rejection